The natural protein, known as CelOCE, was developed at the Brazilian Center for Research in Energy and Materials and is ready ...

Chemical Engineering Department and Mechanical Engineering Department, Université Laval, Québec City, G1K 7P4, Canada, and SEREX, Amqui, Qc, G5J 1K3, Canada Article Views are the COUNTER-compliant sum ...

An illustration of a magnifying glass. An illustration of a magnifying glass.

Evogene Ltd. , a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the first quarter ended March ...

Department of Chemical Engineering, Aristotle University of Thessaloniki, P.O. Box 1517, University City, Thessaloniki 54124, Greece, and Chemical Process Engineering Research Institute, Centre for ...

Richter Gedeon Vegyeszeti Gyar Nyrt announced its acquisition of a significant stake in Granata Bio, a U.S.-based biotech firm. The move positions Richter as a major investor and grants them a seat on ...

Can algae-based polymers replace plastic? Discover how renewable, biodegradable materials from algae are reshaping ...

OpenAI CEO Sam Altman is using his olive oil inefficiently in an “offense to horticulture,” the Financial Times humorously reports. For its “Lunch with the FT” series, the paper joined ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will participate in a fireside chat at the ...

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2025 Earnings Call Transcript May 8, 2025 Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations ...

Less than a day after the Trump administration filed a lawsuit aiming to stop Hawaiʻi from taking oil companies to court for their role in the climate crisis, the state last week became the 10th in ...

Vor Bio is the latest cell therapy company to reach the end of the road. The biotech is immediately winding down clinical and manufacturing operations and laying off almost all staff. Around 95% ...